Skip to main content
OpenTrials
Completed

NCT Number: NCT04412902

Predictors of Recurrence for High Risk Endometrial Cancer Patients

This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

High-risk Endometrial Cancer

Age range

20 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

About this study

The incidence of endometrial cancer is gradually increasing nowaday. The postoperative treatment of high-risk endometrial cancer is also inconsistent. Besides, the recurrence of high-risk endometrial cancer is high.The investigators retrospective study will analyze the factors associated with recurrence of endometrial cancer, especially for different adjuvant therapies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01~2019/09/17.

Exclusion criteria

  • Patients with stage I endometrial cancer do not have high risk factors.

Treatment and study plan

Adjuvant therapy

Drug

Adjuvant chemotherapy and/or radiotherapy

Primary outcomes

  1. Factors affecting overall survival

    Time frame: 10 years

    Factors affecting overall survival

Secondary outcomes

  1. Factors affecting progression-free survival

    Time frame: 10 years

    Factors affecting progression-free survival

Sponsors and collaborators

Lead sponsor

Far Eastern Memorial Hospital

Other

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 2, 2020
Registry last updated
Dec 9, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.